Kamada (KMDA) Cash from Operations Growth (5y) (2017 - 2026)
Kamada (KMDA) Cash from Operations Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.88 Bn | 87.01 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn |
| 3 | Zoetis | 32.31 Bn | 30.37 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - |
| 7 | Viatris | 20.27 Bn | 18.47 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.92 Bn | 16.61 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn |
| 10 | Kamada | 405.25 Mn | 332.11 Mn | 19.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.42% |
| Dec 31, 2025 | -9.91% |
| Sep 30, 2025 | 34.32% |
| Jun 30, 2025 | -5.53% |
| Mar 31, 2025 | 23.21% |
| Dec 31, 2024 | 3.72% |
| Sep 30, 2024 | 29.53% |
| Jun 30, 2024 | 15.62% |
| Mar 31, 2024 | -29.98% |
| Dec 31, 2023 | -0.83% |
| Sep 30, 2023 | -2.40% |
| Jun 30, 2023 | 22.76% |
| Mar 31, 2023 | -14.88% |
| Dec 31, 2022 | -72.08% |
| Sep 30, 2022 | -67.26% |
| Jun 30, 2022 | 51.26% |
| Mar 31, 2022 | 40.34% |
| Dec 31, 2021 | -14.89% |
| Sep 30, 2021 | -29.18% |
| Jun 30, 2021 | -20.15% |